313 related articles for article (PubMed ID: 16763279)
1. Locally recurrent, previously irradiated head and neck cancer: concurrent re-irradiation and chemotherapy, or chemotherapy alone?
Wong SJ; Machtay M; Li Y
J Clin Oncol; 2006 Jun; 24(17):2653-8. PubMed ID: 16763279
[TBL] [Abstract][Full Text] [Related]
2. Intensity-modulated radiotherapy for recurrent and second primary head and neck cancer in previously irradiated territory.
Duprez F; Madani I; Bonte K; Boterberg T; Vakaet L; Derie C; De Gersem W; De Neve W
Radiother Oncol; 2009 Dec; 93(3):563-9. PubMed ID: 19919885
[TBL] [Abstract][Full Text] [Related]
3. Concurrent chemotherapy and re-irradiation for locoregionally recurrent head and neck cancer.
Salama JK; Vokes EE
Semin Oncol; 2008 Jun; 35(3):251-61. PubMed ID: 18544440
[TBL] [Abstract][Full Text] [Related]
4. A review on re-irradiation for recurrent and second primary head and neck cancer.
Kasperts N; Slotman B; Leemans CR; Langendijk JA
Oral Oncol; 2005 Mar; 41(3):225-43. PubMed ID: 15743686
[TBL] [Abstract][Full Text] [Related]
5. Toxicity and outcome analysis of patients with recurrent head and neck cancer treated with hyperfractionated split-course reirradiation and concurrent cisplatin and paclitaxel chemotherapy from two prospective phase I and II studies.
Kramer NM; Horwitz EM; Cheng J; Ridge JA; Feigenberg SJ; Cohen RB; Nicolaou N; Sherman EJ; Babb JS; Damsker JA; Langer CJ
Head Neck; 2005 May; 27(5):406-14. PubMed ID: 15719391
[TBL] [Abstract][Full Text] [Related]
6. Impact of tumor board recommendations on treatment outcome for locally advanced head and neck cancer.
Nguyen NP; Vos P; Lee H; Borok TL; Karlsson U; Martinez T; Welsh J; Cohen D; Hamilton R; Nguyen N; Nguyen LM; Vinh-Hung V
Oncology; 2008; 75(3-4):186-91. PubMed ID: 18841033
[TBL] [Abstract][Full Text] [Related]
7. IMRT reirradiation of head and neck cancer-disease control and morbidity outcomes.
Sulman EP; Schwartz DL; Le TT; Ang KK; Morrison WH; Rosenthal DI; Ahamad A; Kies M; Glisson B; Weber R; Garden AS
Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):399-409. PubMed ID: 18556144
[TBL] [Abstract][Full Text] [Related]
8. A phase II study of primary reirradiation in squamous cell carcinoma of head and neck.
Langendijk JA; Kasperts N; Leemans CR; Doornaert P; Slotman BJ
Radiother Oncol; 2006 Mar; 78(3):306-12. PubMed ID: 16524634
[TBL] [Abstract][Full Text] [Related]
9. The role of re-irradiation of secondary and recurrent head and neck carcinomas. Is it a potentially curative treatment? A practical approach.
Cacicedo J; Navarro A; Alongi F; Gómez de Iturriaga A; Del Hoyo O; Boveda E; Casquero F; Perez JF; Bilbao P
Cancer Treat Rev; 2014 Feb; 40(1):178-89. PubMed ID: 23993769
[TBL] [Abstract][Full Text] [Related]
10. Chemotherapy options for patients with metastatic or recurrent squamous cell carcinoma of the head and neck.
Colevas AD
J Clin Oncol; 2006 Jun; 24(17):2644-52. PubMed ID: 16763278
[TBL] [Abstract][Full Text] [Related]
11. Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501).
Bernier J; Cooper JS; Pajak TF; van Glabbeke M; Bourhis J; Forastiere A; Ozsahin EM; Jacobs JR; Jassem J; Ang KK; Lefèbvre JL
Head Neck; 2005 Oct; 27(10):843-50. PubMed ID: 16161069
[TBL] [Abstract][Full Text] [Related]
12. Reirradiation in squamous cell head and neck cancer: recent developments and future directions.
Langendijk JA; Bourhis J
Curr Opin Oncol; 2007 May; 19(3):202-9. PubMed ID: 17414637
[TBL] [Abstract][Full Text] [Related]
13. A phase II evaluation of a 3-hour infusion of paclitaxel, cisplatin, and 5-fluorouracil in patients with advanced or recurrent squamous cell carcinoma of the head and neck: Southwest Oncology Group study 0007.
Worden FP; Moon J; Samlowski W; Clark JI; Dakhil SR; Williamson S; Urba SG; Ensley J; Hussain MH;
Cancer; 2006 Jul; 107(2):319-27. PubMed ID: 16779801
[TBL] [Abstract][Full Text] [Related]
14. Re-irradiation in the management of isolated neck recurrences: current status and recommendations.
Chopra S; Gupta T; Agarwal JP; Budrukkar A; Ghosh-Laskar S; Dinshaw K
Radiother Oncol; 2006 Oct; 81(1):1-8. PubMed ID: 16971009
[TBL] [Abstract][Full Text] [Related]
15. Phase II study of low-dose paclitaxel and cisplatin in combination with split-course concomitant twice-daily reirradiation in recurrent squamous cell carcinoma of the head and neck: results of Radiation Therapy Oncology Group Protocol 9911.
Langer CJ; Harris J; Horwitz EM; Nicolaou N; Kies M; Curran W; Wong S; Ang K
J Clin Oncol; 2007 Oct; 25(30):4800-5. PubMed ID: 17947728
[TBL] [Abstract][Full Text] [Related]
16. Practical considerations in the re-irradiation of recurrent and second primary head-and-neck cancer: who, why, how, and how much?
Chen AM; Phillips TL; Lee NY
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1211-9. PubMed ID: 22115554
[TBL] [Abstract][Full Text] [Related]
17. Randomized trial of postoperative reirradiation combined with chemotherapy after salvage surgery compared with salvage surgery alone in head and neck carcinoma.
Janot F; de Raucourt D; Benhamou E; Ferron C; Dolivet G; Bensadoun RJ; Hamoir M; Géry B; Julieron M; Castaing M; Bardet E; Grégoire V; Bourhis J
J Clin Oncol; 2008 Dec; 26(34):5518-23. PubMed ID: 18936479
[TBL] [Abstract][Full Text] [Related]
18. Salvage re-irradiation for recurrent head and neck cancer.
Lee N; Chan K; Bekelman JE; Zhung J; Mechalakos J; Narayana A; Wolden S; Venkatraman ES; Pfister D; Kraus D; Shah J; Zelefsky MJ
Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):731-40. PubMed ID: 17379449
[TBL] [Abstract][Full Text] [Related]
19. Salvage therapy with oral etoposide in recurrent and/or metastatic squamous cell carcinoma of the head and neck.
Gedlicka C; Kornfehl J; Turhani D; Burian M; Formanek M
Cancer Invest; 2006; 24(3):242-5. PubMed ID: 16809151
[TBL] [Abstract][Full Text] [Related]
20. Intensity-modulated radiotherapy with concurrent chemotherapy for previously irradiated, recurrent head and neck cancer.
Biagioli MC; Harvey M; Roman E; Raez LE; Wolfson AH; Mutyala S; Han HS; Markoe A
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1067-73. PubMed ID: 17967302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
